The first two weeks of January 2026 sent shockwaves through the healthcare AI ecosystem. Within days of each other, the world's most influential AI companies made their intentions unmistakably clear: healthcare is the next frontier, and they're coming for it with full force.
OpenAI launched ChatGPT Health on January 7th, a dedicated experience allowing users to connect their medical records, wellness apps, and wearable data for personalized health guidance. The company revealed that over 230 million people globally ask health-related questions on ChatGPT every week. Just days later, Anthropic announced Claude for Healthcare at the J.P. Morgan Healthcare Conference, introducing HIPAA-ready infrastructure with connectors to Medicare databases, ICD-10 coding systems, and clinical trial platforms. Google, meanwhile, continues advancing MedGemma, its open-source medical AI model family, achieving 91.1% accuracy on the MedQA benchmark.
For the hundreds of healthcare AI startups that have collectively raised billions in venture capital, this raises an existential question: can they survive when the world's most powerful AI companies are building directly competitive products?
The Scale of the Threat
